Wedbush Securities’s NEVRO CORP. NVRO Stock Holding History

Wedbush Securities’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,495	Closed	-$348K	–	1198
2021 Q1	$348K	Buy	+2,495	New	+$407K	0.02%	742

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wedbush Securities's NVRO Position: Q2 2021 in Review

Wedbush Securities sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 2,495 shares — an estimated $348K sold.

Wedbush Securities first reported a position in NVRO in Q1 2021 and held it in 1 quarter. The position peaked at $348K in Q1 2021. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

Wedbush Securities reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
Wedbush Securities sold 2,495 NEVRO CORP. shares in Q2 2021, an estimated $348K.
Wedbush Securities first reported a position in NEVRO CORP. in Q1 2021 and held it in 1 quarter.
Wedbush Securities's NEVRO CORP. position peaked at $348K in Q1 2021.
207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on Wedbush Securities's 13F filing for Q2 2021, filed 27 Jul 2021.